54
DAFTAR PUSTAKA
Aaron, Chandra,Conley, & Kern, 2010. Epidemiology of Nasal Polyps in Nasal Polyposis. T.M.Onerci & B.J. Ferguson (eds), Springer-Verlag Berlin Heidelberg.
Assanasen, P. & Naclerio, R.M., 2001. Medical & Nasal surgical management of nasal polyps in Current opinion in Otolaryngology and Head and Neck Surgery. Lippincott William and Wilkins Inc, p. 27-36.
Bachert, C., Watelet, J.B., Gevaert, P.& Cauwenberge, P.V., 2005. ”Pharmacological Management of Nasal Polyposis.” Journal of Drug sevaluation 66 (1): 1537-1552.
Bachert, C., 2011. ”Evidence-Based Management of Nasal Polyposis by Intranasal Corticokortikosteroids: From the cause to the clinic.” International Archieves of Allergy-Immunology (155): 309-21.
Badia, L., & Lund, V., 2001. ”Topical Corticosteroids in Nasal Polyposis.” Journal of Drugsevaluation61 (5): 573-578.
Burgel, Cardell, Ueki, & Nadel, 2004. “Intranasal steroids decrease eosinophils but not mucin expression innasal polyps” Eur Respir J 2004; 24: 594–600.
Corey, J.P. & Yilmaz, A.S., 2009. Assessment of Nasal Function in: Ballenger’s Otorhinolaryngology. BC Decker Inc, Connecticut, 17th ed, vol 2, p. 493-9.
Dewi, F., 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun 2010. Tesis Magister Ilmu Kesehatan Telinga, Hidung, Tenggorok, Bedah Kepala dan Leher. FK USU.
Djupesland, P.G., VLckova, I. & Hewson, G., 2010. “Impact of baseline nasal polyp size and previous surgery of efficacy of fluticasone delivered with a novel device: A subgroup analysis.” American Journal of Rhinology and Allergy (24): 291-5.
Ebbens, F.A., Maldonado, M.,de Groot, E.J.J., Alobid, I.,Drunen, C.M., Picado. C.,Fokkens, W.J. & Mullol, J., 2009. “Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps ”Allergy 2009: 64: 96–103 _ 2008
Farrukh, M.S., Rafique,M. & Shaikh, A.A., 2014. “An Experience of Steroid in Recurrent Ethmoidal Nasal Polypsat Tertiary Care Hospital” JLUMHS JANUARY- APRIL 2014; Vol 13: No. 01 09.
Ferguson, B.J. & Orlandi, R.R., 2006. Chronic Hypertrophic Rhinosinusitis and Nasal Polyposis in: Head & Neck Surgery Otolaryngology. Lippincot Williams & Wilkins, 4th ed, Vol 1, p.1-25.
55
Decreases Nasal Eosinophilic Inflammation by Inhibiting Both Cytokine Secretion From Nasal Mucosa Epithelial Cells Cytokine Secretion and Eosinophil Survival”Allergy Clin Immunol
Fisher,1992. ”Pharmacokinetics and Pharmacodynamics of Methylprednisolone when Administered at 8 AM versus 4 PM.” Journal of Clinical Pharmacology Therapy 51: 677-88.
Gevaert, P., Cauwenberge, P.V. and Bachert, C., 2004. Figure of Eosinophils in the Pathophysiology of Nasal Polyposis and the Impact of OralCorticokortikosteroid Treatment (GCS). Thesis submitted as partial fulfilment of the requirements for the degree of doctor in medical sciences. Upper airways Research Laboratory,Department of Otorhinolaryngology, Ghent University Hospital, Belgium.
Hellquist, H.B., 1996. ”Histopathology.” Journal of Allergy and Asthma 17 (5): 237-240.
Holford & Benet, 2005. Farmakokinetik dan Farmakodinamik: Pemilihan Dosis yang Rasional dan Waktu Kerja Obat dalam: Farmakologi Dasar dan Klinik, EGC, Jakarta, edisi 10, h. 41-42.
Hwang, P.H. & Abdal khani, A., 2009. Embryology, Anatomy and Physiology of the nose and Paranasal Sinuses in: Ballenger’s Otorhinolaryngology. BC Decker Inc, Connecticut, 17th ed, Vol 2, p. 455-63.
Jankowski, R., Bouchoua, F., Coffinet, L.& Vignaud, J.M., 2002. ”Clinical factor influencing the eosinophil infiltration of nasal polyps.” American Journal of Rhinology (40): 173-8.
Jόkύti, 2008. Studying histamine, IL-5, IgE and TGF-beta1 in the
pathogenesis of nasal polyposis. Ph.D. dissertation. Semmelweis University, Budapest.
Jonathan corren, 2012. “ Inhibition of interleukin-5 for the threatment of eosinophilic.” Discov med 13 (71) 305-312 April 2012.
Kirtsreesakul, V., 2005. ”Update on Nasal Polyps: Etiopatogenesis.” Journal Medical Association Thailand 88 (12): 1966-72.
Kowalski, M.L., 2011. ”Oral and Nasal Kortikosteroids for Nasal Polyps.” Poland Journal of Allergy and Asthma (11): 187-8.
Kumar, R., Kumar, D. & Parakh, A., 2011. ”Fluticasone furoate: A new intranasal corticokortikosteroid.” Journal of Postgraduate Medicine (58): 79-83.
56
Lund, V.J., 1995. Diagnosis and treatment of nasal polyps.” British Medical Journal (31): 1411-4.
Mangunkusumo, E. & Wardani, R.S., 2007. Polip Hidung dalam: Buku Ajar Ilmu Kesehatan Telinga, Hidung Tenggorok, Kepala dan Leher. Balai Penerbit FKUI, Jakarta, edisi keenam, h. 123-5.
Munir, D., 2008. Histopathology Types of Polyposis in Adam Malik Hospital. Majalah Kedokteran Nusantara, vol.1, h. 1-3.
Mudassir, Azis, A. & Punagi, A.G., 2012. “Analisis Kadar Malondialdehid ( Mda ) PlasmaPenderita Polip Hidung Berdasarkan DominasiSel Inflamasi Pada Pemeriksaan Histopatologi.” Bagian Ilmu Kesehatan Telinga Hidung Tenggorok – Kepala LeherFakultas Kedokteran Universitas Hasanuddin, Makassar.
Mulyamin, W., Azis, A. & Punagi, A.G., 2012. “Pengaruh Terapi Steroid Intranasal Pada Penderita Rinitis Alergi Di Makassar. Tinjauan Pada Aspek; Transpor Mukosiliar, Perbaikan Klinis Dan Kualitas Hidup.” Bagian THT-KL, Fakultas Kedokteran, Universitas Hasanuddin, Makassar.
Mullol J & Alobid I., 2012. “Role of Medical Therapy in the Management of Nasal Polyps” Curr Allergy Asthma Rep (2012) 12:144–153.
Mostafa, H.S., Fawzy, T.O., Ayad, E. & Soliman, A.A., 2013. “Effect of a prolonged topical glucocorticosteroid on interleukin-5 production and eosinophilic recruitment in the nasal submucosal compartment.” The Egyptian Journal of Otolaryngology, 29:151– 155
Mygind, N. and Lildholdt, T., 1996. “Nasal Polyps Treatment: Medical Management.” American Journal of Allergy and Asthma, vol. 17, (5): 275-80.
Newton, J.R. and Ah-See, K.W., 2008. ”A riview of nasal polyposis.” Therapeutic and Clinical Risk Management (2): 507-512.
PERHATI-KL. 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di Indonesia.
Peric, Vojvodic, Durdevic, & Baletic, 2011. ”Correlation between cytokine levels in nasal fluid and eosinophil.” AllergolImmunopathol (Madr).
Piromchai, P., Kasemsiri, P., Laohasiriwong,S. And Thanaviratananich, S., 2013.“Chronic rhinosinusitis and emergingtreatment options”International Journal of General Medicine
Pornsuriyasak, P. & Assanasen, P., 2008. “Intranasal Corticokortikosteroids .” Journal of Siriraj Med (60): 90-5.
57
Rui, 2002. “Concentration, distribution and expression of interleukin-5 in human nasal polyp tissues.” Chinese Medical Journal (9): 1386-9.
Sastre, J. and Mosges, R., 2012. “Local and Systemic Safety of Intranasal Corticokortikosteroids.” Journal Investigation Allergol Clinical Immunology (1): 1-12.
Shun, 2005. ”C-C Chemokine Ligand 2 Gene Expression in Nasal Polyp Fibroblast: Possible Implication in the Pathogenesis of Nasal Polyposis.” The Annals of Otology, Rhinology and Laryngology (11): 879.
Soetjipto, D., Mangunkusumo, E. and Wardani, R.S., 2007. Hidung dalam: Buku Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan Leher. Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Wang, D.Y., 2008. “Significance of Susceptible Gene ExpressionProfiles in Nasal Polyposis” Clinical and Experimental Otorhinolaryngology Vol. 1, No. 4: 177-183.
